Home > Name List By n > N-(3-chloro-4-fluorophenyl)-7-methoxy-6-(3-morpholin-4-ylpropoxy) quinazolin-4-amine

CAS No 184475-35-2 , N-(3-chloro-4-fluorophenyl)-7-methoxy-6-(3-morpholin-4-ylpropoxy)
quinazolin-4-amine

  • Name: N-(3-chloro-4-fluorophenyl)-7-methoxy-6-(3-morpholin-4-ylpropoxy)
    quinazolin-4-amine
  • Synonyms: Gefitinib [USAN];Iressa; ZD-1839; 184475-35-2; Iressa (TN); ZD1839; Irressat;N-(3-chloro-4-fluorophenyl)-7-methoxy-6-(3-morpholin-4-ylpropoxy)
    quinazolin-4-amine; Iressa(TM); ZD 1839;
  • CAS Registry Number:
  • Melting Point: 119-120
  • Density: 1.322g/cm3
  • Refractive index: 1.621
  • Molecular Weight: 446.902363
  • InchiKey: XGALLCVXEZPNRQ-UHFFFAOYSA-N
  • InChI: InChI=1S/C22H24ClFN4O3/c1-29-20-13-19-16(12-21(20)31-8-2-5-28-6-9-30-10-
    7-28)22(26-14-25-19)27-15-3-4-18(24)17(23)11-15/h3-4,11-14H,2,5-10H2,
    1H3,(H,25,26,27)
  • Molecular Formula: C22H24ClFN4O3
  • Molecular Structure:CAS No:184475-35-2 N-(3-chloro-4-fluorophenyl)-7-methoxy-6-(3-morpholin-4-ylpropoxy)<br />quinazolin-4-amine

Related products

Search by region :

Select to

184475-35-2 Gefitinib

  • China TaiZhou HiKong Chemical Co., Ltd. null
  • Tel: +86-18967213045,13957694715
  • Fax: +86-(580)-6033180,6034626
  • Address: Taizhou Economic Technical Development Zone, Taizhou, Zhejiang 318000, null,nullChina
Contact Supplier

184475-35-2 Gefitinib

Contact Supplier

184475-35-2 Gefitinib

  • China Facus Pharmaceutical Co., Ltd. [Manufacturers]
  • Tel: +86-(574)-6237-8411
  • Fax: +86-(574)-6237-8410
  • Address: 24Fl, Yuanjing Building, Beilun, Ningbo, Zhejiang 315800, Ningbo,ZhejiangChina
Contact Supplier

184475-35-2 GEFITINIB

  • United States Carbomer, Inc. [Manufacturer]
  • Tel: 858-552-0992/ (800) 239-7129
  • Fax: 858-552-0999
  • Address: PO Box 261026-1026
    San Diego, CA 92196 null,nullUnited States
Contact Supplier

184475-35-2 Gefitinib

Contact Supplier

184475-35-2 GEFITINIB

  • China Xingcheng Chempharm Co., Ltd [Manufacturer]
  • Tel: +86-576-88525005/ +86-576-88886292
  • Fax: +86-576-88225056
  • Address: B Area, 10F, Yaoda Mansion, 289, Shifu Road, Taizhou, Zhejiang, China 318000 null,nullChina
Contact Supplier

184475-35-2 Gefitinib

  • United States Tecoland Corporation null
  • Tel: +1-(732)-603-9577
  • Fax: +1-(732)-906-1522
  • Address: 100 Menlo Park Drive, Suite 316, Edison, New Jersey 08837-2428, null,nullUnited States
Contact Supplier

184475-35-2 Iressa

Contact Supplier

184475-35-2 Gefitinib

  • China Huei-Ho International Co., Ltd. [Importer/Exporter]
  • Tel: +86-(21)-6273-7219, 6273-6279
  • Fax: +86-(21)-6129-4387, 62735948
  • Address: 20B,No.2,Lane 600,Peakway Tower,Tianshan Road, Shanghai, shanghai 200051, null,ShanghaiChina
Contact Supplier

184475-35-2 Gefitinib

  • China Epochem Co., Ltd. [Manufacturers]
  • Tel: +86-(21)-6760-1595
  • Fax: +86-(21)-6760-1605
  • Address: Building No 7, Xinfei Road 1500, Songjiang Industrial Zone, Songjiang, Shanghai 201611, Shanghai,ShanghaiChina
Contact Supplier

Select to

4/14
Previous 1 2 3 4 5 6 7 8 9 10 Next
References of N-(3-chloro-4-fluorophenyl)-7-methoxy-6-(3-morpholin-4-ylpropoxy)
quinazolin-4-amine
Title: Gefitinib
CAS Registry Number: 184475-35-2
CAS Name: N-(3-Chloro-4-fluorophenyl)-7-methoxy-6-[3-(4-morpholinyl)propoxy]-4-quinazolinamine
Synonyms: 4-(3￠-chloro-4￠-fluoroanilino)-7-methoxy-6-(3-morpholinopropoxy)quinazoline
Manufacturers' Codes: ZD-1839
Trademarks: Iressa (AstraZeneca)
Molecular Formula: C22H24ClFN4O3
Molecular Weight: 446.90
Percent Composition: C 59.13%, H 5.41%, Cl 7.93%, F 4.25%, N 12.54%, O 10.74%
Literature References: Selective epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitor which blocks signal transduction pathways implicated in the proliferation and survival of cancer cells. Prepn: K. H. Gibson, WO 9633980; idem, US 5770599 (1996, 1998 both to Zeneca). LC/MS/MS determn in biological samples: M. Zhao et al., J. Chromatogr. B 819, 73 (2005). Clinical pharmacokinetics and tolerability: H. Swaisland et al., Clin. Pharmacokinet. 40, 297 (2001). In vitro and in vivo inhibition of EGFR-expressing cancer lines: N. G. Anderson et al., Int. J. Cancer 94, 774 (2001). Proposed mechanism of action: A. Hirata et al., Cancer Res. 62, 2554 (2002). Clinical study in non-small cell lung cancer: M. G. Kris et al., J. Am. Med. Assoc. 290, 2149 (2003). Review: C. L. Arteaga, D. H. Johnson, Curr. Opin. Oncol. 13, 491-498 (2001). Review of clinical evaluations: D. Raben et al., Semin. Oncol. 29, Suppl. 4, 37-46 (2002); of use in non-small cell lung cancer: K. Tamura, M. Fukuoka, Expert Opin. Pharmacother. 6, 985-993 (2005).
Properties: Crystals from toluene, mp 119-120°.
Melting point: mp 119-120°
Therap-Cat: Antineoplastic.
Keywords: Antineoplastic; Tyrosine Kinase Inhibitors.